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Summary
Expression of the p16INK4a tumor suppressor sharply increases with age in most mammalian
tissues, and contributes to an age-induced functional decline of certain self-renewing
compartments. These observations have suggested that p16INK4a expression could be a biomarker
of mammalian aging. To translate this notion to human use, we determined p16INK4a expression in
cellular fractions of human whole blood, and found highest expression in peripheral blood T-
lymphocytes (PBTL). We then measured INK4/ARF transcript expression in PBTL from two
independent cohorts of healthy humans (170 donors total), and analyzed their relationship with
donor characteristics. Expression of p16INK4a, but not other INK4/ARF transcripts, appeared to
exponentially increase with donor chronologic age. Importantly, p16INK4a expression did not
independently correlate with gender or body-mass index, but was significantly associated with
tobacco use and physical inactivity. In addition, p16INK4a expression was associated with plasma
interleukin-6 concentration, a marker of human frailty. These data suggest that p16INK4a
expression in PBTL is an easily measured, peripheral blood biomarker of molecular age.
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Introduction
Human aging is characterized by a striking increase in frailty and age-associated diseases
such as cancer, ischemic stroke, coronary artery disease and type 2 diabetes mellitus
(T2DM). A biomarker that can faithfully measure molecular, rather than chronological,
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aging could be used to predict the future risk of these conditions. Work in model systems
has suggested that some aspects of mammalian aging result from a decline in tissue
replicative capacity. This decrease in tissue regeneration and repair in turn has been
suggested to occur as the result of the activation of tumor suppressor mechanisms such as
telomere dysfunction and p16INK4a activation (Campisi, 2003; Finkel et al., 2007; Kim and
Sharpless, 2006).
The p16INK4a tumor suppressor originates from the INK4/ARF (or CDKN2a/b) locus on
chromosome 9p21 which gives rise to two other anti-proliferative protein encoding
transcripts (p15INK4b and ARF) as well as a recently described non-coding RNA, ANRIL
(Broadbent et al., 2008; Pasmant et al., 2007). Expression of p16INK4a has been shown to
markedly increase with aging in most rodent, baboon and human tissues tested (Edwards et
al., 2007; Herbig et al., 2006; Krishnamurthy et al., 2004; Melk et al., 2003; Melk et al.,
2004; Nielsen et al., 1999; Signer et al., 2008; Zindy et al., 1997), and caloric restriction,
which retards aging in rodents, attenuates this age-induced increase in p16INK4a (Edwards et
al., 2007; Krishnamurthy et al., 2004). In mice lacking p16INK4a, an attenuated decline in the
replicative capacity of several self-renewing compartments has been observed, including
hematopoietic stem cells (Janzen et al., 2006), pancreatic β-cells (Krishnamurthy et al.,
2006), neural stem cells (Molofsky et al., 2006) and B-lymphocytes (Signer et al., 2008).
Moreover, inactivation of p16INK4a, but not Arf, partially rescues several age-related
phenotypes in a progeroid mouse strain (Baker et al., 2008). Provocatively, unbiased human
association studies have demonstrated that the genotype of single nucleotide polymorphisms
(SNPs) near the INK4/ARF locus is associated with human age-associated conditions such as
frailty (Melzer et al., 2007), atherosclerotic diseases (Broadbent et al., 2008; Helgadottir et
al., 2008; Helgadottir et al., 2007; Matarin et al., 2008; McPherson et al., 2007; Samani et
al., 2007; The Wellcome Trust Case Control Consortium, 2007), and type 2 diabetes
mellitus (T2DM) (Broadbent et al., 2008; Saxena et al., 2007; Scott et al., 2007; Zeggini et
al., 2007). These observations suggest that the expression of p16INK4a is intimately
associated with cell-intrinsic, molecular aging in humans, and could serve as a biomarker of
this process.
A limitation of these observations for human studies, however, has been the need to measure
p16INK4a in tissues (e.g. brain, bone marrow and pancreas) that are difficult to obtain. In this
work, we therefore sought to develop an easily assessable biomarker of human molecular
age that can be reliably measured longitudinally. Toward that end, we measured INK4/ARF
transcript expression in the cellular fractions of human whole blood. In two independent
cohorts of healthy adults, expression of p16INK4a in peripheral blood T lymphocytes (PBTL)
strongly correlated with donor chronological age, demonstrating an apparent exponential
increase with aging. Additionally, PBTL expression of p16INK4a was positively associated
with tobacco use and physical inactivity, and with serum IL-6 levels, a marker of human
frailty. These data suggest that measurement of p16INK4a in PBTL has the properties of a
useful biomarker of human molecular age.
Results
Expression of p16INK4a in human peripheral blood cells
To develop a peripheral blood biomarker of human molecular age, we first determined the
expression of p16INK4a in different peripheral blood compartments. We isolated six, highly-
enriched cellular fractions from whole blood by Magnetic Activated Cell Sorting (MACS):
T cells (CD3+), B cells (CD19+), monocytes (CD14+), NK cells (CD56+) and granulocytes
(CD15+ or CD16+) (Supp. Fig. 1A). Of these fractions, expression of p16INK4a was highest
in CD3+ T cells (Fig. 1A), and was found to be stable in subjects who consented to re-testing
more than 4 weeks after the initial analysis (Supp. Fig. 1B). Given these results, we decided
Liu et al. Page 2













to focus on PBTL for further study as these cells are relatively abundant in the peripheral
blood, demonstrate easily measured expression of p16INK4a, and are of undisputed
importance with regard to immunologic aging.
Increased p16INK4a expression is associated with chronological age
We next examined p16INK4a mRNA and protein expression in PBTL from two independent,
unselected cohorts of healthy donors aged 18-80 (cohorts described in Supp. Table 1). In
general, associations noted in the exploratory cohort were confirmed in an independent
validation cohort (Supp. Table 1), and aggregate data are shown except where indicated. In
accord with work in other mammalian tissues (Edwards et al., 2007; Herbig et al., 2006;
Krishnamurthy et al., 2004; Melk et al., 2003; Melk et al., 2004; Nielsen et al., 1999; Signer
et al., 2008; Zindy et al., 1997), we noted a strong association between p16INK4a mRNA
expression and chronologic age (Table 1 and Fig. 1B). While protein expression of p16INK4a
also increased with age (Fig. 1C), several technical issues (e.g. importance of sample
handling, ease of measure in large scale) limited the utility of protein quantification.
Therefore, we elected to focus on mRNA quantification for the remainder of the studies. We
found that the correlation (Pearson) with chronologic age was considerably stronger for
log2-transformed p16INK4a (r=0.63) than untransformed p16INK4a expression (r=0.47). In
accord with this result, Sedivy and colleagues have also reported an exponential increase of
other biomarkers of aging in non-human primates (Herbig et al., 2006). These observations
are consistent with the model that molecular age, as estimated by PBTL p16INK4a expression
and other aging biomarkers, increases exponentially with chronologic age.
To address the possibility that the increase of p16INK4a expression in PBTL with age could
be due to age-related changes in T cell differentiation or subset composition, we examined
the expression of memory T cell markers (bcl-2 (Grayson et al., 2000), bcl-XL (Zhang and
He, 2005) and IL-7 receptor α (Huster et al., 2004)) and the ratio of CD4+ versus CD8+ T
cells. Expression of bcl-2, bcl-XL and IL-7R increased minimally, if at all, with age and no
correlation between CD4/CD8 ratio and chronologic age was observed (Supp. Fig. 2A, B, C,
and D, Left panels). Change in the mean expression of all three markers was less than two-
fold across the entire examined age range (Supp. Fig. 2A, B, and C, Left panels). These
markers of T cell differentiation also correlated minimally or not at all with p16INK4a
expression (Supp. Fig. 2A, B, C, and D, right panels). These observations, coupled with the
very large observed changes in p16INK4a observed with aging, suggest that the increased
p16INK4a expression with age is unlikely the result of the reported modest alterations in
PBTL differentiation or composition with age (De Paoli et al., 1988; Naylor et al., 2005;
Utsuyama et al., 1992).
Expression of other INK4/ARF transcripts with aging
We sought to determine the relationship of other INK4/ARF transcripts (ARF, p15INK4b, and
ANRIL) with aging. We and others have previously noted a strong co-correlation between
p16INK4a and Arf expression in rodents, and expression of Arf increases sharply in most
murine tissues with aging (Krishnamurthy et al., 2004; Signer et al., 2007; Zindy et al.,
1997). Importantly, p16INK4a and ARF start with different first exons but share common
second and third exons translated in alternate reading frames (Supp. Fig. 3, reviewed in
(Kim and Sharpless, 2006)). We therefore also measured aggregate INK4a/ARF transcript
levels using primer/probes that span shared exons 2 and 3 (Exon2/3) which detect total
p16INK4a and ARF transcript levels. While strong positive correlations were noted among all
the INK4/ARF-associated transcripts, only p16INK4a expression was associated with
chronological age (Table 1 and Fig. 2). The fact that the observed correlations are partial (R2
~0.40, with R2=1.0 being complete correlation) explains how it is possible that p16INK4a
expression can be significantly associated with both chronologic age and the expression of
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other 9p21 transcripts, while age and p15INK4b/ARF/ANRIL expression are uncorrelated.
Moreover, aggregate p16INK4a and ARF expression measured with exon 2/3 primers did not
correlate with chronologic age; presumably because ARF is the more abundant transcript in
this tissue, at least in donors of younger ages (not shown). Additionally, although ANRIL is
believed to result from a spliced RNA that is anti-sense to p15INK4b (Broadbent et al., 2008;
Pasmant et al., 2007), we did not observe a negative correlation between ANRIL levels and
p15INK4b; but rather, expression of p15INK4b and ANRIL were positively correlated (r=0.56,
p<0.0001). Together, these observations suggest that the expression of p16INK4a in human
PBTL is influenced independently by factors that globally control expression of at least four
transcripts from the INK4/ARF locus, as well as aging-specific factors that influence only
p16INK4a. Donor genetics appears to be a factor that contributes to the global control of
INK4a/ARF expression as we have recently described a strong correlation of all four INK4a/
ARF transcripts with donor genotype of a nearby single nucleotide polymorphism that has
also been associated with atherosclerosis (Liu et al., 2009).
Expression ofp16INK4a is associated with cigarette smoking and physical inactivity
Tobacco use is positively associated with increased risk of many age-related diseases,
particularly atherosclerosis and multiple cancers, and we therefore sought to determine the
relationship between cigarette smoking and p16INK4a expression in PBTL. In linear
regression analysis, expression of p16INK4a increased more rapidly (slope ~2-fold greater)
with advancing age in current smokers compared to non-smokers, with an intermediate
effect observed in former smokers (Fig. 3A). Moreover, we observed evidence of a dosage
effect as p16INK4a expression was associated with cumulative exposure as estimated by
tobacco pack-years (Fig. 3B, Supp. Fig. 4A and Table I). In accord with compelling in vitro
and murine studies (reviewed in ref. (Finkel et al., 2007;Kim and Sharpless, 2006)), these
findings are consistent with the view that exposure to DNA damaging agents and/or other
mutagens such as those present in tobacco smoke accelerate molecular aging.
Exercise likewise has been associated with lower risk of several age-related diseases such as
atherosclerosis and T2DM, while obesity has been associated with higher risk of these
diseases. We noted negative correlations between several reported measures of exercise
habits and p16INK4a expression (Table 1, Fig. 3C and Supp. Fig. 4B). This negative
association was seen with both frequency and amount of exercise and remained significant
after adjusting for age and smoking status (Table 2). A weak but significant Spearman
correlation was observed between p16INK4a expression and obesity as estimated by
categorized body-mass index (BMI, Supp. Fig. 4C). In contrast, p16INK4a expression did not
significantly correlate with absolute, uncategorized BMI values (Supp. Fig. 4D), and no
association with BMI was found in multivariate analysis (Table 2, see also multiple
regression section below). These data suggest that increased molecular aging in PBTL is
associated strongly with reduced exercise, but weakly, if at all, with BMI.
Expression of p16INK4a is associated with IL-6, a serologic marker of aging and frailty
In an effort to determine the functional consequences of increased p16INK4a expression in
PBTL with aging, we investigated its correlation with plasma levels of IL-6, which has been
reproducibly associated with cellular senescence (Coppe et al., 2008; Kuilman et al., 2008)
in vitro as well as frailty and aging in vivo (reviewed in (Ershler and Keller, 2000)). While
no correlation was noted between IL-6 and chronologic age in this small sample (Supp. Fig.
4E), a significant association was seen between levels of IL-6 and p16INK4a expression
(Table 1 and Fig. 3D). As the expression of this marker of human frailty is associated more
strongly with p16INK4a than chronologic age, this observation suggests the intriguing
possibility that molecular age, as estimated by PBTL p16INK4a expression, is a better
predictor of frailty than chronological age.
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Analysis of validation sample and multiple regression analysis
To control for chance associations resulting from the comparison of multiple genes and
parameters in the exploratory cohort, we re-tested significant associations noted in the initial
analysis in an independent validation cohort comprised of 90 subjects (Supp. Table 1).
Comparably strong and statistically significant associations were seen in the validation
cohort (Table I), suggesting that the observed relationships of p16INK4a expression with age,
smoking, exercise, plasma IL-6, and other INK4/ARF transcripts are unlikely to represent
chance associations.
A multiple regression model was first developed using only subjects from the aggregate
cohort for which there was full clinical data (Table 2, N=99). In this model, expression of
p16INK4a was independently associated with chronologic age, smoking pack-years, and
minutes per month of exercise after adjusting for all other covariates. Expression of
p16INK4a was not independently associated with BMI (p=0.91) or gender (p=0.33, see also
Supp. Fig 4F), nor was there a significant effect due to study source (exploratory vs.
validation, p=0.99). Expression of p16INK4a was best described by the model with age, pack-
years, and exercise (min/mon) using the model selection methods described. The relative
effect size of each covariate on p16INK4a and p-values are shown in Table 2. Age had the
most significant effect on p16INK4a expression compared to the other covariates. Significant
results were then confirmed in regression analysis incorporating missing values (total
N=147), yielding similar results to those shown in Table 2.
Discussion
Here, we show that p16INK4a expression in PBTL has the properties of a useful peripheral
blood biomarker of human molecular age. The test is an easily measured, low-cost assay that
can be performed on a small specimen of whole blood with a short turnaround time. The test
demonstrates low intra-individual variability and is highly dynamic with human age. Data
from rodents systems suggest that p16INK4a expression is not merely epiphenomenally
associated with aging, but may also play a causal role in the process in diverse tissues
(Baker et al., 2008; Janzen et al., 2006; Krishnamurthy et al., 2006; Molofsky et al., 2006;
Signer et al., 2008). We further show that p16INK4a expression not only correlates with
chronological age, but is associated with other aging modifying factors and markers of aging
and frailty. These observations suggest that p16INK4a expression may provide an integrated
measure of the effects of chronological age, environmental exposures and host genetics on
molecular aging. Along these lines, it is worth noting that human p16INK4a expression in
zero-hour kidney biopsies prior to transplantation has been recently shown to be a better
predictor of long-term renal allograft function than other donor variables including
chronologic age and telomere length (Koppelstaetter et al., 2008; McGlynn et al., 2008). In
aggregate, these observations suggest that measurement of p16INK4a expression in a given
tissue connotes information regarding intrinsic molecular age which is independent from
chronologic age.
These data identify an intriguing difference between human and rodent aging. In mice and
rats, a marked increase in Arf expression, comparable in magnitude to that of p16INK4a, is
noted with aging (Krishnamurthy et al., 2004; Signer et al., 2008; Zindy et al., 1997). In
human tissues (PBTL (present work) and kidney (Melk et al., 2004)), however, no
association of chronologic age and ARF expression has been noted. Similarly, expression of
murine p16INK4a and Arf increases markedly with in vitro senescence in cultured murine
fibroblasts (Kamijo et al., 1997; Sharpless et al., 2001), but only p16INK4a, and not ARF,
appears to increase during the senescence of human cells (Munro et al., 1999; Wei et al.,
2001). The molecular basis for this difference in the regulation of the INK4/ARF locus
between species is unknown, but it is of interest that similar differences between human and
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murine cells in the patterns of INK4/ARF repression by Polycombgroup (PcG) proteins (e.g.
BMI-1) have been recently reported (Bracken et al., 2007; Kotake et al., 2007). Most
recently, loss of EZH2 expression with concomitant p16INK4a activation has been reported
in pancreatic β-cells in vivo with ageing in humans and mice (Hainan Chen, 2009). These
observations suggest the model that a decrease in PcG repression occurs in all mammals
with aging, with an attendant increased expression of only p16INK4a in humans, but both
p16INK4a and Arf in rodents.
An important consideration in the interpretation of these results is the reliance on PBTL for
sampling. It is likely that the rate of molecular aging will differ across human tissues, and
that donor characteristics will influence molecular aging to a different degree in different
tissues. For example, in a rat model (Krishnamurthy et al., 2004), we noted the greatest
effects of caloric restriction on expression of p16INK4a in the kidney; with little or no effect
on certain other tissues such as the uterus. This observation suggests that the effects of an
age-retarding stimulus (e.g. caloric restriction) on the rate of molecular aging may differ in
distinct tissues of a given individual. Therefore, assays on components of peripheral blood
may or may not be a useful surrogate for molecular age in other tissues or the organism in
toto.
Another limitation of these analyses is that the correlative design does not establish an arrow
of causality between p16INK4a expression and other subject characteristics such as smoking
and exercise. While evidence from model systems combined with the present observations
can be most parsimoniously explained by the model that cigarette smoking potently
accelerates molecular aging, interpreting the inverse correlation of PBTL p16INK4a
expression and exercise is more complex. This observation might signify that exercise
retards the expression of p16INK4a with aging; that individuals with lower p16INK4a are
more able to exercise; or that exercise and PBTL p16INK4a expression co-correlate because
they are both casually related to a third, unknown variable (e.g. certain dietary habits).
Properly designed prospective studies will be needed to understand the relationships
between molecular aging and behaviors such as smoking and exercise.
A determination of telomere length in unfractionated peripheral blood has also been
suggested to be a biomarker of human molecular aging. While both approaches have merit,
we think several aspects of p16INK4a testing are advantageous. Setting aside the biologic
rationale for each assay, p16INK4a expression is more dynamic, and therefore more reliably
measured, with chronologic age. In our sample, untransformed p16INK4a expression changes
on average nearly 10-fold over six decades of adult aging, whereas decreases in telomere
length reported for the same age range are typically less than 2-fold (Allsopp et al., 1995;
Frenck et al., 1998; Rufer et al., 1999; Son et al., 2000; Valdes et al., 2005; Vaziri et al.,
1993). Moreover, although telomere length can be assayed by several methodologies of
varying complexity, we believe the relative ease, low cost and reproducibility of qRT-PCR
are strengths of the PBTL p16INK4a methodology. Lastly, telomere length, at least when
measured by multicolor flow FISH in large human cohorts, appears to change modestly
during young adulthood (e.g. from ages 20-60), with an acceleration in the rate of shortening
after the sixth decade (see for example (Alter et al., 2007; Armanios et al., 2007)). In
contrast, log2-transformed p16INK4a expression significantly changes with aging in young
adults (e.g. compare mean expression in 25 year olds versus 45 year olds in Fig. 1B),
suggesting that this form of molecular `aging' is apparent well before one is `aged'. Relative
disadvantages of PBTL p16INK4a testing are the need for MACS processing and the reliance
on RNA rather than DNA for analysis. While both of these features could limit the utility of
p16INK4a testing on retrospectively collected samples, neither is an important limitation to
prospective testing; for example, for clinical indications.
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In summary, our study suggests that PBTL expression of p16INK4a but not other INK4/ARF
transcripts is a robust biomarker of human molecular age. Expression of this surrogate
marker of molecular age reflects donor chronologic age as well as gerontogenic behaviors
(e.g. smoking, physical inactivity). We believe this biomarker could be used to predict a
donor's risk of future age-related adverse outcomes, to measure the efficacy of anti-aging




This study was approved by the University of North Carolina Institutional Review Board.
Participants were recruited from a central site on the campus of the University of North
Carolina Hospitals in Chapel Hill, NC. After providing informed consent, each participant
completed a brief questionnaire about their health, health behaviors such as smoking and
exercise, and demographics. Each participant also provided a 10-15 ml sample of whole
blood. The exploratory cohort (N=80, Supp. Table 1), consisted of samples obtained from
healthy subjects recruited in Chapel Hill, NC from Sep 27, 2007 to Feb 29, 2008. The
exploratory cohort was also supplemented with whole blood samples from twenty
anonymous donors from the Gulf Coast Regional Blood Center in Houston. These were
shipped overnight at 4 degrees for processing. Extensive testing (not shown) indicated that
this handling did not affect INK4/ARF expression. These samples lacked questionnaire
information and were only included in tests for association with age, sex, and other
transcript expression. A validation cohort (N=90, Supp. Table 1) was recruited in Chapel
Hill, NC from May 19 to May 30, 2008 using the same recruitment and sample handling
techniques. Seven participants consented to a repeat blood draw more than 4 weeks after
initial testing to assess intra-subject variability of testing.
Flow cytometry, cell sorting, western analysis and ELISA
Multiple-color flow cytometry was performed on a CyAn™ ADP flow cytometer (Dako
Cytomation). To exclude subjects with acute illness and chronic condition, all samples were
first examined for T-cell activation by flow cytometry using predefined criteria (> 2% of
CD3+CD25+CD69+ cells in total T cells); one of 171 subjects was excluded by this criteria.
CD3+ PBTL and other peripheral blood cells were enriched directly from whole blood using
AutoMACS™ pro separator (Miltenyi Biotec) after labeling with corresponding magnetic
microbeads (Miltenyi Biotec) and then assessed for purity and viability by flow cytometry
after CD3 and 7AAD staining (Supp. Fig. 1A). All CD3+ T cells were enriched to greater
than 90% purity. Fluorescent-conjugated antibodies used for flow cytometry were from BD
Bioscience. Antibodies used for Western blotting were anti-p16INK4a (BD Bioscience) and
anti-tubulin (Sigma-Aldrich). Quantification was achieved by using a fluorescent secondary
antibody (Alexa Fluor 680, Invitrogen) and an infrared Western quantification system
(Odyssey Infrared Imaging system by Li-Cor Bioscience). Plasma IL-6 concentration was
quantified using ELISA kits (Invitrogen) according to manufacturer's instructions.
Nucleic acid preparation and analysis
RNA was prepared from PBTL using RNeasy mini kit (Qiagen) according to manufacture's
directions. One μg of purified RNA was used for reverse transcription with ImProm-II™ RT
system (Promega) according to manufacture's instructions. Expression of all transcripts was
determined by Taqman® qRT-PCR (Details in Supp. Methods). Except for p16INK4a, ARF
and ANRIL; expression of all transcripts was determined using commercially available
assays from Applied Biosytems. Expression of p16INK4a and ARF was determined as
previously described (Shields et al., 2007). For ANRIL, we developed and validated a qRT-
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PCR assay using primers and probes describe in the Supp. Methods. Transcript expression
levels normalized to 18s ribosomal RNA (Hs03003631, Applied Biosystems) and β2
microglobulin (β2M, Hs99999907, Applied Biosystems) are presented as log2-transformed
data except where indicated.
Statistical analysis
Variables were first modeled by simple linear regression (see supplemental statistical
methods). Pearson's correlation and R-squared statistics were computed in these instances.
Multiple linear regression was then used to model the relationship between p16INK4a and
covariates such as age, pack-years, exercise minutes per month, body mass index (BMI) and
gender in aggregate data. The subjects without any clinical data for above covariates were
excluded from the analysis (N=147 analyzed). We performed model selection using
stepwise selection, backward elimination as well as criterion based methods such as AIC
(Akaike Information Criterion)(Akaike, 1973) and BIC (Bayesian Information Criterion)
(Schwarz, 1978). We also added an indicator variable for study (exploratory vs. validation)
to test whether there is a significant effect caused by different datasets. To account for
missing values in the dataset, especially in the exercise and pack-years, we conducted
multiple regression incorporating the cases with missing values using the EM (Expectation
Maximization) algorithm (Ibrahim, 1990) in LogXact. A p-value less than 0.05 were
considered statistically significant. In addition, p-values were adjusted for multiple testing
using the Bonferroni method in the pair-wise comparisons and exact p-values were
computed when the sample size was small. Computations were performed using SAS (v.
9.1.3, SAS Institute Inc), StatXact and LogXact (v. 7, Cytel Software Corporation).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Expression of p16INK4a in PBTL is associated with chronologic age
(A) Comparison of relative p16INK4a expression in different cell types of the peripheral
blood. Error bars indicate standard error of the mean (SEM). (B) Linear relationship
between log2-transformed p16INK4a mRNA expression and chronological age. Aggregate
data from the exploratory and validation cohorts are shown. The correlation coefficients and
p-values of individual cohort are shown in Table 1. Dotted lines indicate the 95% confidence
intervals (CI) of the fitted line. (C) Expression of p16INK4a protein increases with
chronologic age in a representative subset of patients.
Liu et al. Page 12













Figure 2. Expression of other INK4/ARF transcripts is associated with p16INK4a expression, but
not age
Dotted lines indicate the 95% confidence intervals (CI). The correlations between the
variables shown in the left panels are significant (p<0.0001) while those in the right panels
are not significant (p>0.4). Data shown are from the exploratory cohort.
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Figure 3. Expression of p16INK4a is associated with smoking, exercise and plasma IL-6
concentrations
(A) The comparison of p16INK4a -age linear regression among never smokers, former
smokers and current smokers is shown for the combined cohort. Slope comparison: Current,
7.5 ± 0.1 × 10-2; Never, 3.9 ± 0.7 × 10-2. *p<0.05, adjusted for multiple comparisons. (B)
Expression of p16INK4a is associated with tobacco exposure. Categorized pack-years: Mild
(>0, ≤5); Moderate (5-10); Heavy (11-30); Severe (31-50); Extreme (51 and up). (C)
Decreased p16INK4a mRNA expression is associated with increased exercise intensity. (D)
Plasma IL-6 levels are associated with increased p16INK4a expression. Aggregate data from
the exploratory and the validation cohorts are shown in a, b, and c; whereas d represents data
only from the validation cohort. The Pearson correlations and p-values in each cohort are
shown in Table 1. Dotted lines in c and d indicate 95% CI.
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Table 2
Multiple regression model of p16INK4a expression and covariates.
Variable* Label Parameter estimate ±SE** p-value
Age Per chronological year 0.04±0.005 <.0001
Pack-yrs 0: Pack-yrs <= 5, 1: Pack-yrs > 5 0.36±0.17 0.0348




Parameter estimate indicates change in Log2-transformed p16INK4a expression per unit change of covariant. SE: standard error
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